Duttaroy, A. and Yoburn, B.C. In vivo regulation of u-opioid
receptor density and gene expression in CXBK and outbred swiss
webster mice. Synapse, 2000, 37:118-124.
PubMed
Lee, S.C. and Yoburn, B.C. The effect of nimodipine on opioid
antagonist-induced upregulation and supersensitivity. Pharmacology,
Biochemistry and Behavior, 2000, 66: 347-351.
PubMed
Shen, J., Gomes, A.B., Gallagher, A., Stafford, K and Yoburn,
B.C. The role of cAMP-dependent protein kinase (PKA) in opioid
agonist-induced u-opioid receptor downregulation and tolerance in
mice, Synapse, 2000, 38: 322-327.
PubMed
Stafford, K., Gomes, A.B., Shen, J and Yoburn, B.C. µ-opioid
receptor downregulation contributes to opioid tolerance in vivo,
Pharmacology, Biochemistry and Behavior, 2001, 69: 233-237.
PubMed
Gomes, B.A., Shen, J., Stafford, K., Patel, M. and Yoburn B.C.
µ-Opioid receptor down-regulation and tolerance are not equally
dependent upon G-protein signaling, Pharmacology, Biochemistry and
Behavior, 2002, 72:273- 278.
PubMed
Patel, M., Gomes, B., Patel, C and Yoburn, B.C.
Antagonist-induced µ-opioid receptor upregulation decreases
G-protein receptor kinase-2 and dynamin-2 abundance in mouse spinal
cord. European Journal of Pharmacology, 2002, 446:37-42.
PubMed
Patel, M.B., Patel, C.N., Rajashekara, V. and Yoburn, B.C.
Opioid agonists differentially regulate µ-opioid receptors and
trafficking proteins in vivo. Molecular Pharmacology, 2002, 62:
1464-1470.
PubMed
Yoburn, B.C., Gomes, B.A., Rajashekara, V., Patel, C. and Patel,
M. Role of Gialpha2-protein in opioid tolerance and mu-opioid
receptor downregulation in vivo. Synapse. 2003, 47:109-16.
PubMed
Patel, C.N., Rajashekara, V., Patel, K, Purohit, V. and Yoburn,
B.C.Chronic opioid antagonist treatment selectively regulates
trafficking and signaling proteins in mouse spinal cord. Synapse.
2003, 50:67–76.
PubMed
Rajashekara, V., Patel, C. N., Patel, K., Purohit, V. and
Yoburn, B. C. Chronic Opioid Antagonist Treatment Dose-Dependently
Regulates µ-Opioid Receptors and Trafficking Proteins In Vivo.
Pharmacology, Biochemistry and Behavior, 2003, 75: 909-913.
PubMed
Yoburn, B.C., Purohit, V., Patel, K. and Zhang, Q. Opioid
agonist and antagonist treatment differentially regulates
immunoreactive µ-opioid receptors and dynamin-2 in vivo. European
Journal of Pharmacology, 2004, 498:87-96.
PubMed see erratum
Zhang, Q. Purohit, V. and Yoburn, B.C. Continuous opioid agonist
treatment dose-dependently regulates µ-opioid receptors and
dynamin-2 in mouse spinal cord, Synapse, 2005, 56:123-128.
PubMed
Pawar, M., Kumar, P., Sunkaraneni, S, Sirohi, S, Walker, E.A.
and Yoburn, B.C. Opioid agonist efficacy predicts the magnitude of
tolerance and the regulation of μ-opioid receptors and dynamin-2,
European Journal of Pharmacology, 2007, 563:92-101.
PubMed
Sirohi, S., Kumar, P., and Yoburn, B.C m-Opioid receptor
upregulation and functional supersensitivity are independent of
antagonist efficacy. Journal of Pharmacology and Experimental
Therapeutics, 2007, 323:701–707.
PubMed